Healios Oncology Nutrition, LLC, is a Houston, Texas-based company that manufactures proprietary dietary supplements as an adjunctive nutritional support for cancer patients, dental patients, and others who are experiencing mucosal stress.
The company’s flagship product is Healios™ Glutamine Complex, a product designed to promote healthy mucosal tissues in patients receiving multiple therapies, including biological (for example which target the mTOR pathway), chemotherapy (for example doxorubicin and other agents known to cause mouth, throat or esophageal soreness), and radiation treatment (especially involving mouth, head, neck, and esophagus).
The benefits of supplementing one’s diet with the nutrients found in Healios™ has been clinically demonstrated in published scientific studies and the nutritional benefits of Healios™ are now being further studied at a world-class cancer hospital.
You can learn more about Healios as it relates to your requrements by by clicking on the menu options from the home page.
Who discovered Healios™ ?
Peter M. Anderson, MD, PhD. who has served as a Professor, Department of Pediatrics Patient Care, Division of Pediatrics, Curtis Distinguished Professor, The University of Texas MD Anderson Cancer Center, Houston, TX originally developed the science and patents that formed the foundation for Healios™. Dr. Anderson, is now a Staff Physician at the Cleveland Clinic.
Dr. Anderson discovered the benefits of supplementing the amino acid glutamine (a key ingredient in Healios™) as part of his cancer patients’ treatment to reduce the toxic side effects of therapy in the 1990’s. He was seeking to address the well-known side effects involving the mouth caused by cancer treatments. Biological regimens, chemotherapy, and radiation can have moderate or severe effects on the digestive tract where lost epithelial cells are not replaced at an adequate rate. The cumulative damage to the epithelial lining quickly leads to problems in mouth comfort and difficulty in swallowing, leading to decreased nutrient absorption and a pattern of diminished nutrition and increased damage.
How did Dr. Anderson discover the benefits of the Healios™ glutamine suspension for the treatment of cancer-related mucositis?
Dr. Anderson was able to find a way to greatly increase the absorption of glutamine by a factor of over 1,000 times by putting it in a suspension that would “feed the digestive lining” specifically in the mouth, throat, and esophagus. By combining glutamine with a blend of synergistic ingredients, he was able to achieve the desired effect, while still keeping the taste good and the suspension easy to use for patients. The concept was tested successfully in people with cancer in one pilot study and 3 larger randomized placebo, double-blind trials. The HEALIOS™ formula is an improved result of Dr. Anderson’s original research.
How did Healios™ Oncology Nutrition come together?
After years of patient testing and refining the formula, Dr. Anderson partnered with a team of top oncologists and a world-class nutraceutical company to achieve his dream of making Healios™ available to patients world-wide. Dr. Anderson is on a mission to make Healios™ a part of the standard dietary regimen for those who need it, so that he can improve the lives of as many patients as possible.
Click Here For More Information About Dr. Anderson + -
Present Title & Affiliation
Staff Physician, The Cleveland Clinic.
- Carolinas HealthCare System
Education & Training
|1981||Mt. Sinai School of Medicine, New York, NY, MD, Medicine|
|1980||City University of New York, New York, NY, PHD, Biomedical Sciences|
|1975||University of Minnesota, Minneapolis, MN, BA, Summa Cum Laude, Psychology|
|1/1985-1/1988||Hematology/Oncology/Bone Marrow Transplant Fellowship, University of Minnesota, Minneapolis, MN|
|1/1981-1/1985||Combined Internal Medicine and Pediatrics Residency, Duke University Medical Center, Durham, NC|
Honors and Awards
|Alpha Omega Alpha, 1980|
|Career Development Award, American Cancer Society, 1989|
|Excellent in Teaching Award- Mayo Medical School, 2003|
|Annie Weber Memorial Lecture, MACC Fund, 2008|
|Curtis Distinguished Professor, 2009-2013|
|MD Anderson, Outstanding Patient Educator, 2010|
|MD Anderson Pediatric Physician Excellence in Teaching Award- from fellows 2012|
|MD Anderson Pediatric Physician Excellence in Teaching Award- from Residents 2012|
|Sarcoma Alliance Outstanding Care Award-2012|
|Kufos Lecture, Akron Children’s Hospital 2012|
|Visiting Lecturer, Midland Memorial Hospital, Midland TX 3-6-13 “ Sarcomas in young People”|
|Visiting Professor and Royal Dames of Ocala Lecture, University of Florida Shands Cancer Center and Univ FL Veterinary Teaching Hospital, Gainesville FL 4/10/13. “New Information to improve Pediatric Cancer Care and Sarcoma Care|
|American Society of Clinical Oncology
|American Society of Hematology
|American Society of Pediatric Hematology/Oncology
|Connective Tissue Oncology Society
|Sarcoma Alliance for Research through Collaboration (SARC)
|Societe Internationale D'Oncologie Pediatrique/ International Society of Paediatric Oncology